Back

Medscape, LLC

  • Mycobacterium avium-intracellulare Infection

Cracking the Case on MAC Lung Disease: From Early Clues to Emerging Treatment Strategies

The goal of this activity is for learners to be better able to recognize early signs of refractory Mycobacterium avium complex lung disease (MAC-LD), address treatment failures, and apply emerging strategies for the management of MAC-LD.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.5 credits

MOC types

ABIM — Medical KnowledgeUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Faculty 1

All faculty

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Commercial Support
  • Released
    Nov 14, 2025
  • Last day to claim credit
    Nov 15, 2026 5 weeks left